Astrazeneca plc ADR (NASDAQ:AZN) shares, rose in value, with the stock price up by 1.72% to the previous day’s close as strong demand from buyers drove the stock to $72.04.
Actively observing the price movement in the recent trading, the stock is buoying the session at $70.82, falling within a range of $71.3 and $72.23. The value of beta (5-year monthly) is 0.173 whereas the PE ratio is 28.94 over 12-month period. Referring to stock’s 52-week performance, its high was $87.68, and the low was $61.24. On the whole, AZN has fluctuated by -1.33% over the past month.
With the market capitalization of Astrazeneca plc ADR currently standing at about $223.41 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Apr-29. The company’s Forward Dividend Ratio is 1.55, with its dividend yield at 2.15%.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 57.82B, with a low estimate of 13.65B and a high estimate of 14.47B. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 14.07B.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that AZN’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of Hold while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the PEG ratio is about 2.53, with the price of AZN currently trading nearly 1.20% and 1.73% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 55.75, while the 7-day volatility ratio is showing 1.70% which for the 30-day chart, stands at 1.50%. Furthermore, Astrazeneca plc ADR (AZN)’s beta value is 0.36.
A comparison of Astrazeneca plc ADR (AZN) with its peers suggests the former has fared considerably weaker in the market. AZN showed an intraday change of 1.72% in today’s session so far, and over the past year, it grew by 9.95%%.
Data on historical trading for Astrazeneca plc ADR (NASDAQ:AZN) indicates that the trading volumes over the past 10 days have averaged 4.45 and over the past 3 months, they’ve averaged 4.75 million. According to company’s latest data on outstanding shares, there are 3.10 billion shares outstanding.
Nearly 0.01% of Astrazeneca plc ADR’s shares belong to company insiders and institutional investors own 16.57% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 7.45 million shares as on 2025-06-13, resulting in a short ratio of 1.73. According to the data, the short interest in Astrazeneca plc ADR (AZN) stood at 24.00 of shares outstanding as of 2025-06-13; the number of short shares registered in 2025-05-15 reached 7.34 million. The stock has fallen by -6.60% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the AZN stock heading into the next quarter.
